Evidence map›Paper›PMID 37189582›Full record

ReviewDiagnostics (Basel, Switzerland)2023

Endocardial Fibroelastosis as an Independent Predictor of Atrioventricular Valve Rupture in Maternal Autoimmune Antibody Exposed Fetus: A Systematic Review with Clinicopathologic Analysis.

Monika Kantilal Kotecha, Khurshid Merchant, Charmaine Jiahui Chan, Jonathan Tze Liang Choo, Krishna Revanna Gopagondanahalli, Dyan Zhewei Zhang, Teng Hong Tan, Sreekanthan Sundararaghavan

Open access · goldAbstract readReview
In one paragraph

Review in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Monika Kantilal KotechaDepartment of Paediatric Subspecialties, Cardiology Service, KK Women's and Children's Hospital, Singapore 229899, Singapore.ORCID 0000-0003-0477-9931
Khurshid MerchantDepartment of Pathology and Laboratory Medicine, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Charmaine Jiahui ChanDepartment of Paediatric Subspecialties, Cardiology Service, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Jonathan Tze Liang ChooDepartment of Paediatric Subspecialties, Cardiology Service, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Krishna Revanna GopagondanahalliDepartment of Neonatology, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Dyan Zhewei ZhangDepartment of Paediatric Subspecialties, Cardiology Service, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Teng Hong TanDepartment of Paediatric Subspecialties, Cardiology Service, KK Women's and Children's Hospital, Singapore 229899, Singapore.
Sreekanthan SundararaghavanDepartment of Paediatric Subspecialties, Cardiology Service, KK Women's and Children's Hospital, Singapore 229899, Singapore.
KK Women's and Children's Hospital · SG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeonatal lupus (NL) is a clinical syndrome that develops in the fetus as a result of maternal autoimmune antibodies. Congenital complete heart block (CHB) is the most common manifestation, while extranodal cardiac manifestations of NL, such as endocardial fibroelastosis (EFE) and myocarditis, are rare but more serious. Less is known about this atrioventricular valve rupture due to valvulitis as a consequence of maternal autoantibodies. We have described a case of cardiac neonatal lupus with an antenatally detected CHB patient who developed mitral and tricuspid valve chordal rupture at 45 days of age. We compared the cardiac histopathology and the fetal cardiac echocardiographic findings of this case with another fetus that was aborted after being antenatally diagnosed with CHB but without valvar rupture. A narrative analysis after a systematic review of the literature regarding atrioventricular valve apparatus rupture due to autoimmune etiology along with maternal characteristics, presentation, treatment, and outcome have been discussed in this article.

objectivesTo describe published data on atrioventricular valve rupture in neonatal lupus, including clinical presentation, diagnostic evaluation, management, and outcomes.

methodsWe conducted a PRISMA-compliant descriptive systematic examination of case reports that included accounts of lupus during pregnancy or in the newborn period that resulted in an atrioventricular valve rupture. We gathered information on the patient's demographics, the details of the valve rupture and other comorbidities, the maternal therapy, the clinical course, and the results. We also used a standardized method to evaluate the cases' quality. A total of 12 cases were investigated, with 11 cases drawn from 10 case reports or case series and 1 from our own experience.

resultsTricuspid valve rupture (50%) is more common than mitral valve rupture (17%). Unlike mitral valve rupture, which occurs postnatally, the timing of tricuspid valve rupture is perinatal. A total of 33% of the patients had concomitant complete heart block, while 75% of the patients had endocardial fibroelastosis on an antenatal ultrasound. Antenatal changes pertaining to endocardial fibroelastosis can be seen as early as 19 weeks of gestation. Patients with both valve ruptures generally have a poor prognosis, especially if they occur at close intervals.

conclusionAtrioventricular valve rupture in neonatal lupus is rare. A majority of patients with valve rupture had antenatally detected endocardial fibroelastosis in the valvar apparatus. Appropriate and expedited surgical repair of ruptured atrioventricular valves is feasible and has a low mortality risk. Rupture of both atrioventricular valves occurring at close intervals carries a high mortality risk.

Indexed as

anti La/SSB antibodiesanti-Ro/SSA antibodiescomplete heart blockendocardial fibroelastosismaternal autoantibodiesmitral valve ruptureneonatal lupustricuspid valve rupture

Identifiers

PMID37189582
PMCPMC10137427
OpenAlexW4366596634

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.